Milestone Scientific (MLSS) EBITDA (2010 - 2026)

Milestone Scientific has disclosed EBITDA across 17 years of filings, most recently posting -$828083.0 for Q1 2026.

• EBITDA for Q1 2026 came in at -$828083.0, up 58.55% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.5 million (up 37.9% YoY), and the FY2025 annual result was -$5.7 million, up 15.69% from the prior year.
• EBITDA came in at -$828083.0 for Q1 2026 at Milestone Scientific, up from -$1.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$828083.0 in Q1 2026 to a low of -$2.9 million in Q2 2022.
• The 5-year median for EBITDA is -$1.8 million (2024), against an average of -$1.7 million.
• Across the five-year window, EBITDA plunged 93.02% in 2022 and jumped 58.55% in 2026, its largest moves.
• Milestone Scientific's EBITDA stood at -$2.0 million in 2022, then gained by 1.74% to -$2.0 million in 2023, then declined by 3.17% to -$2.0 million in 2024, then jumped by 47.13% to -$1.1 million in 2025, then rose by 23.3% to -$828083.0 in 2026.
• The last three EBITDA figures came in at -$828083.0 (Q1 2026), -$1.1 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.